$BDPT (Bioadaptives, Inc.) — Recently ~$0.002–$0.0035 with tens of millions in share volume.
Recent updates include retiring debt from a major convertible investor (removing overhang), scaling e-commerce for the MyndSystem nootropic platform, operational readiness for product launches, and details on the Xcellara stem-cell-related wellness platform (including a cardiovascular formula claiming clinical data). These press releases appeared in late July.
otcmarkets.com